The FDA’s Arthritis Advisory Committee firmly voted against recommending the Novartis drug, Ilaris, as a treatment for gout. The 11 to 1 vote against backing the drug stemmed from safety concerns over the risk for patients to develop serious infections and other problems. While the panel noted that the data did demonstrate the drug is [...]
